Theravance Biopharma, Inc. (FRA:0TB)
Germany · Delayed Price · Currency is EUR 15.80
0.00 (0.00%)
At close: Jan 2, 2026
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of €829.44 million as of January 9, 2026. Its market cap has increased by 79.13% in one year.
Market Cap
829.44M
Enterprise Value
581.75M
Revenue
68.46M
Ranking
n/a
PE Ratio
33.16
Stock Price
€15.80
Market Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has increased from 16.00 to 829.44M, an increase of 5,184,007,481.46%. That is a compound annual growth rate of 358.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 829.44M | 2.72% |
| Dec 31, 2025 | 807.48M | 80.66% |
| Dec 31, 2024 | 446.95M | -11.74% |
| Dec 29, 2023 | 506.39M | -28.28% |
| Dec 30, 2022 | 706.03M | -1.40% |
| Dec 31, 2021 | 716.07M | -22.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 195.73B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.21B |
| Deutsche Bank Aktiengesellschaft | 63.34B |